Zhenzhen Li

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 526 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +19

Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis

Ming Li, Pin Liang, Zhenzhen Li et al. · Frontiers in Microbiology · 2015 · 108 citations · Full text

Dysbiosis, Immunology, Gastroenterology +16

Effect of Dexmedetomidine on Preventing Agitation and Delirium After Microvascular Free Flap Surgery: A Randomized, Double-Blind, Control Study

Xudong Yang, Zhenzhen Li, Chunyan Gao et al. · Journal of Oral and Maxillofacial Surgery · 2015 · 67 citations

Medicine, Postoperative Pain Management, Patient Safety +8

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Blood · 2018 · 42 citations

Nociceptor-localized cGMP-dependent protein kinase I is a critical generator for central sensitization and neuropathic pain

Fei Wang, Sui‐Bin Ma, Zhi‐Cheng Tian et al. · Pain · 2020 · 41 citations